Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement

Detalles Bibliográficos
Autores principales: Zhang, Qiqi, Zu, Cheng, Ni, Fang, Yang, Zhe, Zhang, Zhiye, Zhang, Mingming, Huang, He, Hu, Yongxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162942/
https://www.ncbi.nlm.nih.gov/pubmed/35702481
http://dx.doi.org/10.1016/j.reth.2022.05.007
_version_ 1784719820956106752
author Zhang, Qiqi
Zu, Cheng
Ni, Fang
Yang, Zhe
Zhang, Zhiye
Zhang, Mingming
Huang, He
Hu, Yongxian
author_facet Zhang, Qiqi
Zu, Cheng
Ni, Fang
Yang, Zhe
Zhang, Zhiye
Zhang, Mingming
Huang, He
Hu, Yongxian
author_sort Zhang, Qiqi
collection PubMed
description
format Online
Article
Text
id pubmed-9162942
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society for Regenerative Medicine
record_format MEDLINE/PubMed
spelling pubmed-91629422022-06-13 Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement Zhang, Qiqi Zu, Cheng Ni, Fang Yang, Zhe Zhang, Zhiye Zhang, Mingming Huang, He Hu, Yongxian Regen Ther Letter to the Editor Japanese Society for Regenerative Medicine 2022-05-31 /pmc/articles/PMC9162942/ /pubmed/35702481 http://dx.doi.org/10.1016/j.reth.2022.05.007 Text en © 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Zhang, Qiqi
Zu, Cheng
Ni, Fang
Yang, Zhe
Zhang, Zhiye
Zhang, Mingming
Huang, He
Hu, Yongxian
Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement
title Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement
title_full Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement
title_fullStr Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement
title_full_unstemmed Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement
title_short Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement
title_sort pomalidomide-based regimens bridging car-t therapy in multiple myeloma with central nervous system involvement
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162942/
https://www.ncbi.nlm.nih.gov/pubmed/35702481
http://dx.doi.org/10.1016/j.reth.2022.05.007
work_keys_str_mv AT zhangqiqi pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement
AT zucheng pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement
AT nifang pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement
AT yangzhe pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement
AT zhangzhiye pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement
AT zhangmingming pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement
AT huanghe pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement
AT huyongxian pomalidomidebasedregimensbridgingcarttherapyinmultiplemyelomawithcentralnervoussysteminvolvement

Ejemplares similares